Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

Visualizza tutta la documentazione

32809

Supelco

Desogestrel

VETRANAL®, analytical standard

Sinonimo/i:

13-Ethyl-11-methylene-18,19-dinor-17α-4-pregnen-20-yn-17-ol

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(2)

About This Item

Formula empirica (notazione di Hill):
C22H30O
Numero CAS:
54024-22-5
Peso molecolare:
310.47
Numero CE:
258-929-4
Numero MDL:
MFCD00869346
Codice UNSPSC:
41116107
ID PubChem:
329754335
NACRES:
NA.24

Grado

analytical standard

Livello qualitativo

100

Nome Commerciale

VETRANAL®

Durata

limited shelf life, expiry date on the label

tecniche

HPLC: suitable
gas chromatography (GC): suitable

applicazioni

pharmaceutical (small molecule)

Formato

neat

Stringa SMILE

CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

InChI

1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1
RPLCPCMSCLEKRS-BPIQYHPVSA-N

Informazioni sul gene

human ... PGR(5241)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

Desogestrel is a novel progestational steroid developed for utilization in oral contraceptives.

Applicazioni

Desogestrel may be used as an analytical reference standard for the determination of the analyte in:
  • Contraceptives and river water samples by high performance liquid chromatography/ion-trap mass spectrometry (LC-IT MS).
  • Pharmaceutical samples by LC-MS.

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Note legali

VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany

Pittogrammi

Health hazardEnvironment
GHS08,GHS09

Avvertenze

Danger

Indicazioni di pericolo

H360FD,H410

Classi di pericolo

Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 1B

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
BCCF0214
BCBS2116V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Evaluation of the sensitivity of miniaturized liquid chromatography-electrospray ionization-mass spectrometry for pharmaceutical analysis.
Kranendijk M, et al.
Journal of Separation Science, 28(14), 1796-1802 (2005)
Gabriele S Merki-Feld et al.
Cephalalgia : an international journal of headache, 33(5), 340-346 (2013-01-09)
Migraine seems to be substantially related to hormonal changes. However, migraine, but also the use of combined oral contraceptives (COC), is associated with an increased risk for vascular events. Therefore progestagen-only contraception is an important alternative to combined preparations. Clinical
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Matejicek D and Kuban V
Analytica Chimica Acta, 588(2), 304-315 (2007)
Tessa Madden et al.
Obstetrics and gynecology, 120(5), 1053-1059 (2012-10-24)
To estimate whether women who receive an immediate postabortion etonogestrel subdermal implant have higher discontinuation rates than women who undergo an interval insertion (insertion not associated with a recent pregnancy). This was a secondary analysis of the Contraceptive CHOICE Project.
Petra M Casey et al.
Contraception, 87(3), 370-374 (2012-09-11)
Bleeding irregularities represent the most common etonogestrel subdermal implant (ESI) removal indication. ESI placements (n=304) from June 2007 to April 2011 were grouped by removal indications. Group characteristics were compared using one-way analysis of variance, Kruskal-Wallis and χ(2) test. Of
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.